Medical News

RSS

Nonin Medical announces name change of capnography manufacturing center

Nonin Medical, Inc. today announced that its Hudiksvall-based capnography manufacturing center, formerly MedAir AB, has changed its name to Nonin Medical AB and expanded its operations to better serve Nonin Medical's European customers and distributors.

6 Oct 2010

Latino community not aware of Alzheimer's disease: Survey

According to the Alzheimer's Association "Hispanic Perceptions of Alzheimer's Disease" survey, which was funded by MetLife Foundation and released today during National Hispanic Heritage Month, 64 percent of survey respondents felt that the Latino community is not very aware or not at all aware of Alzheimer's disease.

6 Oct 2010

SAFC expands fermentation capabilities in Israel facility

SAFC, a member of the Sigma-Aldrich® Group (Nasdaq: SIAL), today announced the completion of its state-of-the-art expansion of its Jerusalem, Israel facility. The additional capacity expands SAFC's contract manufacturing capabilities in large molecule recombinant proteins and small molecule Active Pharmaceutical Ingredients (APIs) through fermentation, including High Potent APIs (HPAPIs) and secondary metabolites.

6 Oct 2010

CDC grant to support community-based public health project in RI and CT

A $250,000 grant from the Centers for Disease Control and Prevention (CDC) will support a Rhode Island Hospital research study aimed at reducing the state's leading cause of accidental death among adults. Researchers will explore the use and effectiveness of statewide prescription monitoring programs (PMP) in reducing the number of accidental overdose deaths involving prescription opioids like OxyContin and Vicodin in both Rhode Island and Connecticut.

6 Oct 2010

Researchers investigate whole-genome data to uncover new mutations for CAD risk

The Coronary ARtery DIsease Genome-wide Replication And Meta-Analysis (CARDIoGRAM) published in Circulation Cardiovascular Genetics, an American Heart Association journal consists of data from every published whole-genome study on genetic mutations in heart attack or CAD risk. Researchers are also pooling data from several unpublished genome-wide association studies to see if any new mutations can be uncovered.

6 Oct 2010

Health IT may bring unintended consequences

The Philadelphia Inquirer: As the Obama administration nudges the health system toward electronic medical records, researchers have identified some unintended consequences.

6 Oct 2010

CTTC, Spero enter sales agreement for Calmare medical devices

Competitive Technologies, Inc. announced today that it has entered into a sales agreement with Spero Pain Relief Therapy, LLC. Spero, based in St. George, UT, opened its first of 14 planned pain clinics using CTTC's Calmare Pain Therapy medical device last month.

6 Oct 2010

Optical technology shows potential for prescreening patients at high risk for lung cancer

Researchers from Northwestern University and NorthShore University HealthSystem (NorthShore) have developed a method to detect early signs of lung cancer by examining cheek cells in humans using pioneering biophotonics technology.

6 Oct 2010

Universite de Montreal study links office work with obesity

Working nine-to-five may be the way to make a living, but it may be padding more than the wallet. According to a new study from the Universit- de Montr-al, office-workers have become less active over the last three decades and this decreased activity may partly explain the rise in obesity. Their findings, published in the early online edition of Preventive Medicine, may have health implications for the millions of people toiling behind their desks.

6 Oct 2010

Accuray receives SBIR grant to develop high-energy X-ray source for Homeland Security applications

Accuray Incorporated, a global leader in the field of radiosurgery, announced today that the company was awarded a $1 million Small Business Innovation Research (SBIR) grant by the U.S. Government to be used toward further development of a high-energy X-ray source for Homeland Security applications.

6 Oct 2010

HHS adds 1,000 companies to early retiree benefit program

Congress Daily: The federal government added 1,000 companies to the "early retiree benefit program established under the healthcare overhaul law, bringing the total number of companies participating to 3,000. The $5 billion program is a stopgap measure meant to help cover retired Americans over the age of 55 who are not eligible for Medicare."

6 Oct 2010

Investigations on child maltreatment may not improve modifiable risk factors: CPS

Household investigations for suspected child maltreatment by Child Protective Services may not be associated with improvements in common, modifiable risk factors including social support, family functioning, poverty and others, according to a report in the October issue of Archives of Pediatrics and Adolescent Medicine, one of the JAMA/Archives journals.

6 Oct 2010

SJMHS and IHA announce strategic merger to develop new integrated health network

Saint Joseph Mercy Health System (SJMHS) and IHA, the region's leading physician group practice, both of Ann Arbor, Mich., today announced a strategic merger with the goal of developing a new integrated health network. The merger is expected to be effective on or before December 31, at which time IHA will be a member of SJMHS and will initially serve as the integrated physician enterprise for these St. Joseph Mercy Hospital markets: Washtenaw, Livingston and portions of western Wayne and south western Oakland counties.

6 Oct 2010

Insulin-sensitizing drugs may offer new treatments for kidney failure

Evidence reported in the October issue of Cell Metabolism, a Cell Press publication, offers a completely new explanation for why people with diabetes account for more than half of all patients requiring dialysis or kidney transplantation. It appears that insulin has a significant influence on the structure and proper function of a particular group of very specialized cells, known as podocytes, that are integral to the kidney's ability to do its job filtering blood.

6 Oct 2010

Researchers discover biomarker for allergy can originate from mother

Allergies occur when the defence mechanisms of the immune system malfunction and misread normal substances entering the body as invading pathogens. Antibodies are part of our biochemical arsenal for combating viruses, bacteria, parasites and other alien substances, but during an allergic reaction the antibody, known as IgE, is directed against usually harmless substances such as grass pollen, nuts, pets or eggs. However, researchers from COPSAC (Copenhagen Studies on Asthma in Childhood) at the Faculty of Health Sciences, University of Copenhagen recently discovered indications that IgE in the blood of the umbilical cord could originate from the mother, and decided to conduct a focused study on this.

6 Oct 2010

Saneron receives grant to develop safety guidelines for transplanting HUBC cells in Alzheimer's disease

The National Institutes of Health has awarded a three-year, $2.6-million grant to the University of South Florida and Tampa-based biotechnology company Saneron-CCEL Therapeutics, Inc., to establish dosing and safety guidelines for transplanting human umbilical cord blood cells (HUBC) into animal models of Alzheimer's disease.

6 Oct 2010

Varian, IMRIS enter agreement to co-develop new MR-guided radiation therapy system for cancer

Varian Medical Systems, Inc., and IMRIS Inc. have concluded an agreement to co-develop an innovative new MR-guided radiation therapy system for use in treating a variety of cancers.

6 Oct 2010

Bernanke: Aging, health costs challenge U.S. future

Federal Reserve Chairman Ben S. Bernanke issued a new warning Monday about aging and health care costs.

6 Oct 2010

Low level of testosterone increases risk for Alzheimer's disease

Low levels of the male sex hormone, testosterone, in older men is associated with the onset of Alzheimer's disease, according to research by a team that includes a Saint Louis University scientist.

6 Oct 2010

USP announces revision schedule for Model Guidelines Version 5.0

As the Medicare Model Guidelines-a listing of therapeutic categories and pharmacologic classes that Medicare Part D plans can utilize when developing their formularies-undergo revision for the first time in three years, the U.S. Pharmacopeial Convention (USP) is announcing its revision schedule and the expanded opportunities for public input as it develops Version 5.0.

6 Oct 2010